Intel vs Qualcomm
INTC and QCOM side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How INTC and QCOM compare
Intel is the larger company, worth 1.8 times as much as Qualcomm ($332B against $185B).
Intel grew revenue faster over the last twelve months (12.1% versus −2.6% for Qualcomm).
Qualcomm keeps more of each dollar of sales as profit, with a net margin of 31.6% compared with −20.1% at Intel.
Qualcomm pays a dividend yielding 2.1%; Intel does not pay one.
Qualcomm scores higher on the StockData Score (14 against 6 for Intel), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | INTC | QCOM |
|---|---|---|
| Size and price | ||
| Market cap | $332B | $185B |
| Share price | $62.50 | $176.57 |
| Change, 1 year | 62.5% | 2.9% |
| Change, 5 years | 26.2% | −4.6% |
| Beta (5Y) | 1.67 | 1.53 |
| Employees | 109K | 57K |
| StockData Score | ||
| Total score | 6 | 14 (better) |
| Valuation score | 1 | 3 (better) |
| Growth score | 2 | 2 |
| Performance score | 0 | 3 (better) |
| Health score | 3 | 4 (better) |
| Dividend score | 0 | 2 (better) |
| Valuation | ||
| P/E | – | 13.9× |
| P/S | 5.5× | 4.3× (better) |
| P/B | 2.9× | – |
| EV/EBITDA | 196× | 18.7× (better) |
| P/FCF | 88.2× | 21.4× (better) |
| PEG | – | 0.54 |
| FCF yield | 1.1% | 4.7% (better) |
| Fair value | – | $193.43 |
| Margin of safety | – | 8.7% |
| Growth | ||
| Revenue growth (TTM) | 12.1% (better) | −2.6% |
| Revenue growth, 5Y average | −7.5% | 5.1% (better) |
| Net income growth (TTM) | −6177% | 146% (better) |
| EPS growth (TTM) | −24200% | 153% (better) |
| EPS growth, 5Y average | – | 10.0% |
| Profitability | ||
| Gross margin | 39.9% | 53.1% (better) |
| Operating margin | 2.9% | 20.1% (better) |
| Net margin | −20.1% | 31.6% (better) |
| FCF margin | 6.3% | 20.1% (better) |
| Return on equity | −10.9% | – |
| Return on invested capital | 1.2% | – |
| Financial health | ||
| Debt / equity | 0.44 | – |
| Net debt / EBITDA | −2.20 | 0.72 (better) |
| Interest coverage | 1.5× | 12.6× (better) |
| Current ratio | 2.21 (better) | 1.86 |
| Altman Z-score | 2.81 | 5.67 (better) |
| Piotroski F-score | 6 | 6 |
| Dividends and buybacks | ||
| Dividend yield | – | 2.1% |
| Years of dividend growth | – | 17 |
| Dividend growth, 5Y average | – | 6.4% |
| Buyback yield | – | 4.1% |
| Shareholder yield | 0.00% | 6.1% (better) |
| Ownership | ||
| Held by institutions | 66.3% | 80.2% |
| Held by insiders | 0.07% | 0.08% |
| Insider net buying, 12 months | $12.5M (better) | −$21.4M |
| Superinvestors holding | 6 (better) | 4 |
| Short interest, % of float | 2.9% | 2.8% |
Go deeper
- INTC stock overview
- INTC income statement
- INTC valuation and score
- QCOM stock overview
- QCOM income statement
- QCOM valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.